Advanced therapies hold great promise for patients, including those with rare diseases, but face a range of challenges, such as technological hurdles, regulatory and quality complexities, and access limitations. This panel addresses these challenges and explores innovative approaches and opportunities to overcome these obstacles, focusing also on how the collaboration between regulators, industry, and patients can improve access to advanced therapies.
May 5, 16:30 - 17:15, room MCH Lounge
| Name | Position | Institution |
|---|---|---|
| Nathalie Schober-Ladani | Head Commercial | Luminance Health |
| Name | Position | Institution |
|---|---|---|
| Joanna Hanley | Head Quality Assurance | Luminance Health |
| Julia Djonova | Leiterin Advanced Therapy Medicinal Products | Swissmedic |
| Ghada Ibrahim | President | PACRT-Geneva |
| Tom Eaton | Co-Founder | Limula SA |
We support pharma, biotech and medtech companies with cross-functional consulting services for sustainable success and continuously uphold GxP standards while navigating dynamic and international regulatory landscapes across the lifecycle of medicinal products, devices and combination products.
